The 3rd In Vivo Cell Engineering & Gene Editing Summit is an exclusive platform offering the latest advances in preclinical development, IND-enabling studies, first clinical data readouts, and more, while also providing clarity on the full in vivo landscape.

This is your chance to unite with industry giants like Capstan Therapeutics, Editas Medicine, NanoCell Therapeutics, Carisma Therapeutics, Mustang Bio, iECURE, and many others, for exclusive access to groundbreaking discoveries and networking opportunities, propelling your pipelines to new heights!

Event Link here.